What is Evommune 's aggregate assigned value?

Evommune (EVMN) reported aggregate assigned value of $8.38M in Q1 2026.

What does aggregate assigned value mean?

Represents the total valuation assigned to a set of assets, liabilities, or equity instruments, often used in the context of complex financial transactions or derivative accounting. It provides insight into the total economic impact of specific corporate actions on the balance sheet.

Evommune EVMN Aggregate Assigned Value

Aggregate Assigned Value at other companies

Kayne Anderson BDCKBDC

$100M—

Kayne Anderson BDCKBDC

$100M—

Acuity BrandsAYI

$840M-6.7%

Goldman Sachs BDCGSBD

$108.28M—

Goldman Sachs BDCGSBD

$1.37B-11.5%

Bain Capital Specialty FinanceBCSF

$1.09B-4.5%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:AggregateAssignedValue.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's aggregate assigned value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's aggregate assigned value?: Evommune (EVMN) reported aggregate assigned value of $8.38M in Q1 2026.
What does aggregate assigned value mean?: Represents the total valuation assigned to a set of assets, liabilities, or equity instruments, often used in the context of complex financial transactions or derivative accounting. It provides insight into the total economic impact of specific corporate actions on the balance sheet.